DK1631373T3 - Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse - Google Patents

Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse

Info

Publication number
DK1631373T3
DK1631373T3 DK04735882T DK04735882T DK1631373T3 DK 1631373 T3 DK1631373 T3 DK 1631373T3 DK 04735882 T DK04735882 T DK 04735882T DK 04735882 T DK04735882 T DK 04735882T DK 1631373 T3 DK1631373 T3 DK 1631373T3
Authority
DK
Denmark
Prior art keywords
micropellets
formulations
preparation
active material
fluidized bed
Prior art date
Application number
DK04735882T
Other languages
English (en)
Inventor
Norbert Poellinger
Manfred Struschka
Franz X Schwarz
Armin Prasch
Bernhard Luy
Original Assignee
Glatt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glatt Gmbh filed Critical Glatt Gmbh
Application granted granted Critical
Publication of DK1631373T3 publication Critical patent/DK1631373T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
DK04735882T 2003-06-07 2004-06-03 Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse DK1631373T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10325989A DE10325989A1 (de) 2003-06-07 2003-06-07 Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
PCT/EP2004/005993 WO2004108266A1 (de) 2003-06-07 2004-06-03 Mikropellets, verfahren zur ihrer herstellung sowie deren verwendung

Publications (1)

Publication Number Publication Date
DK1631373T3 true DK1631373T3 (da) 2009-04-14

Family

ID=33494906

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04735882T DK1631373T3 (da) 2003-06-07 2004-06-03 Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse

Country Status (9)

Country Link
US (1) US20060115539A1 (da)
EP (1) EP1631373B1 (da)
JP (1) JP2006527223A (da)
AT (1) ATE418383T1 (da)
DE (2) DE10325989A1 (da)
DK (1) DK1631373T3 (da)
ES (1) ES2318295T3 (da)
PT (1) PT1631373E (da)
WO (1) WO2004108266A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
WO2005053640A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
WO2005089718A2 (en) 2004-03-23 2005-09-29 Novartis Ag Pharmaceutical compositions
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102006001554A1 (de) * 2006-01-05 2007-07-12 Ipc Process-Center Gmbh & Co. Micropellets für die Herstellung von Tiernahrungspellets
JP5141115B2 (ja) * 2006-07-11 2013-02-13 大正製薬株式会社 不快味を呈する薬物含有製剤粒子
WO2008067164A2 (en) * 2006-11-15 2008-06-05 Abbott Laboratories Solid pharmaceutical dosage formulations
WO2008097658A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Encapsulated picoplatin
WO2009073711A1 (en) 2007-12-04 2009-06-11 Remedy Pharmaceuticals, Inc. Improved formulations and methods for lyophilization and lyophilates provided thereby
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
EP2599477A1 (en) 2011-11-30 2013-06-05 Lunamed AG 4-Phenylbutyric acid sustained release formulation
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
EP3717550A2 (en) * 2017-12-01 2020-10-07 Cable Components Group LLC Foamable compositions and methods for fabricating foamed articles
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
CN117413659B (zh) * 2023-12-19 2024-04-19 蒙草生态环境(集团)股份有限公司 一种实验室用种子包衣丸化装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565475D1 (en) * 1984-04-07 1988-11-17 Bayer Ag Process and apparatus for the production of granules
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE19514187C1 (de) * 1995-04-21 1996-05-15 Degussa Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
EP1027887B1 (en) * 1999-02-10 2008-08-13 Pfizer Products Inc. Matrix controlled release device
US6264983B1 (en) * 1999-09-16 2001-07-24 Rhodia, Inc. Directly compressible, ultra fine acetaminophen compositions and process for producing same
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
WO2002092106A1 (en) * 2001-05-11 2002-11-21 Pacific Pharmaceuticals Limited Taste masking pharmaceutical composition
JP4833464B2 (ja) * 2001-11-28 2011-12-07 大正製薬株式会社 難溶性薬物含有固形製剤の製造方法

Also Published As

Publication number Publication date
ES2318295T3 (es) 2009-05-01
EP1631373A1 (de) 2006-03-08
WO2004108266A1 (de) 2004-12-16
DE502004008734D1 (de) 2009-02-05
DE10325989A1 (de) 2005-01-05
ATE418383T1 (de) 2009-01-15
US20060115539A1 (en) 2006-06-01
PT1631373E (pt) 2009-02-16
JP2006527223A (ja) 2006-11-30
EP1631373B1 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
DK1631373T3 (da) Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse
MXPA05012821A (es) Formulacion farmaceutica que comprende un agente activo insoluble en agua.
MX2007016021A (es) Particulas que tienen material hidrofobico en estas.
WO2005025536A3 (en) Dry powder composition comprising co-jet milled particles for pulmonary inhalation
WO2001032830A3 (en) Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
AU2003276118A1 (en) Method for producing aqueous dispersions
WO2007092846A3 (en) 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
WO2003043631A3 (en) Method for identification of tumor targeting enzymes
WO2006017836A3 (en) 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace)
WO2006102163A3 (en) Transfection reagents for non-adherent suspension cells
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
SI1546322T1 (sl) Vektorji na osnovi transpozona in metode integracije nukleinskih kislin
WO2007059008A3 (en) N-substituted indenoisoquinolines and syntheses thereof
WO2006027521A3 (fr) Procede d'obtention d'un principe actif raffermissant et ledit actif
WO2006055532A3 (en) Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
MXPA05007792A (es) Prodrogas de propofol derivadas de aminoacido, composiciones y usos de las mismas.
WO2006057945A3 (en) 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007092839A3 (en) Macrocycle derivatives useful as inhibitors of beta-secretase (bace)
WO2007040574A3 (en) Biomimetic nanocomposite
WO2006009733A3 (en) Frozen tissue microarray
WO2005007117A3 (en) Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
DE602004024902D1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
ATE468398T1 (de) Herstellungsverfahren zur produktion aktiver und löslicher proteine in prokaryonten und polycistronische vektoren dafür
WO2003099202A3 (en) Beta-secretase inhibitors
WO2006002627A3 (en) Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use